CynergisTek Stock Forecast, Price & News

CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions

How has CynergisTek's stock been impacted by COVID-19?

CynergisTek's stock was trading at $2.53 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CTEK stock has decreased by 41.5% and is now trading at $1.48.
View which stocks have been most impacted by COVID-19.

Are investors shorting CynergisTek?

CynergisTek saw a decline in short interest in the month of October. As of October 29th, there was short interest totaling 120,500 shares, a decline of 27.1% from the October 14th total of 165,400 shares. Based on an average daily trading volume, of 334,900 shares, the short-interest ratio is presently 0.4 days.
View CynergisTek's Short Interest.

How were CynergisTek's earnings last quarter?

CynergisTek, Inc. (NYSEAMERICAN:CTEK) issued its earnings results on Thursday, November, 11th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.22. CynergisTek had a negative trailing twelve-month return on equity of 48.97% and a negative net margin of 76.21%.
View CynergisTek's earnings history.

Who are CynergisTek's key executives?

CynergisTek's management team includes the following people:

• Michael H. McMillan, President, Chief Executive Officer & Director
• Tim McMullen, Chief Operating Officer
• Paul Thomas Anthony, Chief Financial Officer, Secretary & Treasurer
• David S. Finn, Executive Vice President-Strategic Innovation
• Benjamin Denkers, Executive Vice President-Operations

Who are some of CynergisTek's key competitors?

Some companies that are related to CynergisTek include OmniComm Systems (OMCM), Research Solutions (RSSS), Quhuo (QH), Heritage Global (HGBL), TuanChe (TC), MOGU (MOGU), Logiq (LGIQ), ALJ Regional (ALJJ), 36Kr (KRKR), Global Internet of People (SDH), The OLB Group (OLB), BSQUARE (BSQR), DynTek (DYNE), Pacific West Bank (PWBO) and Molecular Data (MKD).
View all of CTEK's competitors.

What other stocks do shareholders of CynergisTek own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include SeaChange International (SEAC), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Invesco (IVZ), VBI Vaccines (VBIV), Actinium Pharmaceuticals (ATNM), Centennial Resource Development (CDEV), Genocea Biosciences (GNCA), Inovio Pharmaceuticals (INO) and Matinas BioPharma (MTNB).

What is CynergisTek's stock symbol?

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

Who are CynergisTek's major shareholders?

CynergisTek's stock is owned by a number of retail and institutional investors. Top institutional investors include Horton Capital Management LLC (6.18%), Essex Investment Management Co. LLC (2.28%) and Perritt Capital Management Inc. (1.26%). Company insiders that own CynergisTek stock include Dana Davis Sellers, John Lawrence Sr Flood Sr, Mark D Roberson, Michael Henry Mcmillan and Robert Mccashin.
View institutional ownership trends for CynergisTek.

Which major investors are selling CynergisTek stock?

CTEK stock was sold by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc..
View insider buying and selling activity for CynergisTek or view top insider-selling stocks.

Which major investors are buying CynergisTek stock?

CTEK stock was purchased by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, and Horton Capital Management LLC. Company insiders that have bought CynergisTek stock in the last two years include Dana Davis Sellers, John Lawrence Sr Flood Sr, Mark D Roberson, Michael Henry Mcmillan, and Robert Mccashin.
View insider buying and selling activity for CynergisTek or or view top insider-buying stocks.

How do I buy shares of CynergisTek?

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CynergisTek's stock price today?

One share of CTEK stock can currently be purchased for approximately $1.48.

How much money does CynergisTek make?

CynergisTek has a market capitalization of $17.94 million and generates $18.87 million in revenue each year. The company earns $-18.47 million in net income (profit) each year or ($1.16) on an earnings per share basis.

How many employees does CynergisTek have?

CynergisTek employs 107 workers across the globe.

What is CynergisTek's official website?

The official website for CynergisTek is www.cynergistek.com.

Where are CynergisTek's headquarters?

CynergisTek is headquartered at 11940 JOLLYVILLE ROAD SUITE 300N, AUSTIN TX, 78759.

How can I contact CynergisTek?

CynergisTek's mailing address is 11940 JOLLYVILLE ROAD SUITE 300N, AUSTIN TX, 78759. The company can be reached via phone at (512) 402-8550, via email at [email protected], or via fax at 949-614-0701.